Literature DB >> 31769087

One decade ago, one decade ahead in huntington's disease.

Edward J Wild1, Sarah J Tabrizi1.   

Abstract

Entities:  

Keywords:  Huntington's disease; antisense therapy; huntingtin; neurodegeneration

Mesh：

Substances：

Year:  2019        PMID： 31769087     DOI： 10.1002/mds.27849

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   9.698


× No keyword cloud information.
  3 in total

1.  Divergent Effects of the Nonselective Adenosine Receptor Antagonist Caffeine in Pre-Manifest and Motor-Manifest Huntington's Disease.

Authors:  Jannis Achenbach; Andreas Matusch; David Elmenhorst; Andreas Bauer; Carsten Saft
Journal:  Biomedicines       Date:  2022-05-27

Review 2.  Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing.

Authors:  Stephen C Cunnane; Mark J Millan; Eugenia Trushina; Cecilie Morland; Alessandro Prigione; Gemma Casadesus; Zane B Andrews; M Flint Beal; Linda H Bergersen; Roberta D Brinton; Suzanne de la Monte; Anne Eckert; Jenni Harvey; Ross Jeggo; Jack H Jhamandas; Oliver Kann; Clothide Mannoury la Cour; William F Martin; Gilles Mithieux; Paula I Moreira; Michael P Murphy; Klaus-Armin Nave; Tal Nuriel; Stéphane H R Oliet; Frédéric Saudou; Mark P Mattson; Russell H Swerdlow
Journal:  Nat Rev Drug Discov       Date:  2020-07-24       Impact factor: 84.694

3.  Resurrection of sildenafil: potential for Huntington's Disease, too?

Authors:  Jannis Achenbach; Simon Faissner; Carsten Saft
Journal:  J Neurol       Date:  2022-05-28       Impact factor: 6.682
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.